{"id":4776,"date":"2025-02-03T11:17:04","date_gmt":"2025-02-03T01:17:04","guid":{"rendered":"\/eu-uk\/?p=4776"},"modified":"2025-02-03T13:06:36","modified_gmt":"2025-02-03T03:06:36","slug":"orthocell-submits-canada-regulatory-application-to-commence-sales-of-remplir-into-us75million-canadian-market","status":"publish","type":"post","link":"\/eu-uk\/blog\/2025\/02\/03\/orthocell-submits-canada-regulatory-application-to-commence-sales-of-remplir-into-us75million-canadian-market\/","title":{"rendered":"Orthocell Submits Canada Regulatory Application to Commence Sales of Remplir\u2122 into US$75million Canadian market"},"content":{"rendered":"<p>Orthocell has announced it has submitted an application to Health Canada for a Medical Device Licence (MDL) to sell its leading nerve repair product Remplir\u2122 into the US$75 million Canadian nerve repair market.<\/p>\n<p>Health Canada is the regulatory authority responsible for regulating the importation, manufacture, export, and supply of medical devices.<\/p>\n<p>Evaluation of Orthocell\u2019s application is now in progress with clearance expected in the second half of 2025.<\/p>\n<p><a href=\"https:\/\/bit.ly\/OCC-Canada-submission\">Click to read the ASX Release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has announced it has submitted an application to Health Canada for a Medical Device Licence (MDL) to sell its leading nerve repair product Remplir\u2122 into the US$75 million Canadian nerve repair market.<\/p>\n","protected":false},"author":2,"featured_media":4778,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4776"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4776\/revisions"}],"predecessor-version":[{"id":4777,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4776\/revisions\/4777"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4778"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4776"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}